Comparative analysis of medicines varieties and dosage forms between UAE and China
10.12206/j.issn.2097-2024.202207059
- VernacularTitle:阿联酋与我国药品品种和剂型的比较分析
- Author:
Kehan ZHU
1
;
Jing CHEN
1
Author Information
1. School of Pharmacy, Naval Medical University, Shanghai 200433, China.
- Keywords:
United Arab Emirates;
China;
pharmaceutical varieties;
dosage forms;
comparative study
- From:
Journal of Pharmaceutical Practice and Service
2022;40(5):454-463
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the supply situation of the UAE’s medicinal market and provide reference for Chinese medicines which are going to import into the UAE. Methods The data related to the existing varieties and dosage forms in the UAE’s medicinal market were collected and analyzed, and compared to the medicines in China. Results To December 31st, 2021, the number of existing pharmaceutical products in the UAE was 5 395 and the number of varieties was 1 637. According to the statistical results of the New Pharmacotherapeutics (18th Edition), the number of pharmaceutical varieties in China was 1 558. The number of overlapping pharmaceutical varieties between the two countries was 604, and the differences mainly focus on medicines of alimentary tract and metabolism, anti-infectives for systemic use, medicines for the nervous system, antiparasitic products, insecticides and repellents. There were 194 pharmaceutical dosage forms in the UAE, with oral administration, injectable administration and dermal administration ranking among the top three. Conclusion There are certain commonalities and also differences in pharmaceutical varieties and dosage forms between China and the UAE, which indicated that our pharmaceutical varieties need to be investigated in detail before importing into the UAE. At the same time, China also could learn from the experience of the UAE and strengthen the research of new medicines and mechanical combinations to further enrich the domestic pharmaceutical market.
